Low Concentration ALA-PDT in Treatment of Skin Ulcer

Sponsor
Sichuan Provincial People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04689243
Collaborator
(none)
28
1
2
24
1.2

Study Details

Study Description

Brief Summary

Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ALA-PDT
  • Procedure: red light
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Study of Low Concentration ALA-PDT in Treatment of Skin Ulcer
Actual Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Dec 26, 2020
Anticipated Study Completion Date :
Dec 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: ALA-PDT

Procedure: ALA-PDT
Low concentration ALA-PDT, 3 times a week.

Other: red light

Procedure: red light
red light, 3 times a week.

Outcome Measures

Primary Outcome Measures

  1. ulcer area size [Change from Baseline ulcer area size at 24 hours after the last treatment.]

    The ulcer area size was measured

Secondary Outcome Measures

  1. total bacterial load [Change from Baseline total bacterial load at 24 hours after the last treatment.]

    Levels of total bacteria were tested

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • chronic skin wounds that involved the dermis and did not heal in three months or did not exhibit a tendency toward healing
Exclusion Criteria:
  • allergies to photosensitizers and their solvents, serious medical illnesses, such as severe heart disease, severe liver or kidney dysfunction, systemic infection or any concomitant infection that would require treatment with an additional antimicrobial agent, the use of topical or systemic antibiotics within one month prior to treatment. Pregnant or lactating women were also excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sichuan Provincial People's Hospital Chengdu Sichuan China 610031

Sponsors and Collaborators

  • Sichuan Provincial People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yujie Mao, principal investigator, Sichuan Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT04689243
Other Study ID Numbers:
  • 2018QN02
First Posted:
Dec 30, 2020
Last Update Posted:
Dec 30, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 30, 2020